Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Ondansetron 4mg tablets
0406000S0AAABAB
|
Ondansetron hydrochloride | Ondansetron hydrochloride | Central Nervous System | 48,310 |
|
Ondansetron 8mg tablets
0406000S0AAACAC
|
Ondansetron hydrochloride | Ondansetron hydrochloride | Central Nervous System | 13,039 |
|
Ondansetron 4mg/5ml oral solution sugar free
0406000S0AAAGAG
|
Ondansetron hydrochloride | Ondansetron hydrochloride | Central Nervous System | 5,947 |
|
Ondansetron 4mg orodispersible tablets
0406000S0AAAKAK
|
Ondansetron hydrochloride | Ondansetron hydrochloride | Central Nervous System | 2,686 |
|
Ondansetron 4mg orodispersible films sugar free
0406000S0AAAMAM
|
Ondansetron hydrochloride | Ondansetron hydrochloride | Central Nervous System | 2,248 |
|
Ondansetron 4mg/2ml solution for injection ampoules
0406000S0AAAAAA
|
Ondansetron hydrochloride | Ondansetron hydrochloride | Central Nervous System | 744 |
|
Ondansetron 8mg orodispersible films sugar free
0406000S0AAANAN
|
Ondansetron hydrochloride | Ondansetron hydrochloride | Central Nervous System | 586 |
|
Ondansetron 8mg orodispersible tablets
0406000S0AAALAL
|
Ondansetron hydrochloride | Ondansetron hydrochloride | Central Nervous System | 538 |
|
Ondansetron 4mg oral lyophilisates sugar free
0406000S0AAAIAI
|
Ondansetron hydrochloride | Ondansetron hydrochloride | Central Nervous System | 472 |
|
Ondansetron 8mg/4ml solution for injection ampoules
0406000S0AAADAD
|
Ondansetron hydrochloride | Ondansetron hydrochloride | Central Nervous System | 306 |
|
Ondansetron 8mg oral lyophilisates sugar free
0406000S0AAAJAJ
|
Ondansetron hydrochloride | Ondansetron hydrochloride | Central Nervous System | 150 |
|
Ondansetron 8mg/5ml oral solution sugar free
0406000S0AAAPAP
|
Ondansetron hydrochloride | Ondansetron hydrochloride | Central Nervous System | 150 |
|
Setofilm 4mg orodispersible films
0406000S0BEAAAM
|
Setofilm | Ondansetron hydrochloride | Central Nervous System | 106 |
|
Zofran Melt 4mg oral lyophilisates
0406000S0BBAIAI
|
Zofran | Ondansetron hydrochloride | Central Nervous System | 37 |
|
Zofran 4mg/5ml syrup
0406000S0BBAGAG
|
Zofran | Ondansetron hydrochloride | Central Nervous System | 31 |
|
Setofilm 8mg orodispersible films
0406000S0BEABAN
|
Setofilm | Ondansetron hydrochloride | Central Nervous System | 29 |
|
Zofran Melt 8mg oral lyophilisates
0406000S0BBAJAJ
|
Zofran | Ondansetron hydrochloride | Central Nervous System | 25 |
|
Ondansetron 16mg suppositories
0406000S0AAAHAH
|
Ondansetron hydrochloride | Ondansetron hydrochloride | Central Nervous System | 16 |
|
Ondansetron 4mg/5ml oral liquid
0406000S0AAAFAF
|
Ondansetron hydrochloride | Ondansetron hydrochloride | Central Nervous System | 9 |
|
Zofran 8mg tablets
0406000S0BBACAC
|
Zofran | Ondansetron hydrochloride | Central Nervous System | 6 |
|
Ondansetron 4mg/2ml inj pre-filled syringes
0406000S0AAAQAQ
|
Ondansetron hydrochloride | Ondansetron hydrochloride | Central Nervous System | 5 |
|
Ondansetron 8mg/4ml inj pre-filled syringes
0406000S0AAARAR
|
Ondansetron hydrochloride | Ondansetron hydrochloride | Central Nervous System | 2 |
|
Zofran 4mg tablets
0406000S0BBABAB
|
Zofran | Ondansetron hydrochloride | Central Nervous System | 2 |
|
Zofran 8mg/4ml solution for injection ampoules
0406000S0BBALAD
|
Zofran | Ondansetron hydrochloride | Central Nervous System | 2 |
|
Zofran Flexi-amp 4mg/2ml solution for injection ampoules
0406000S0BBAEAA
|
Zofran | Ondansetron hydrochloride | Central Nervous System | 2 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.